INVEST 2024 will be back at the Ritz Hotel in Chicago, May 21-22, and we are once again on the hunt for novel startups who will pitch LIVE in front of venture capitalist judges….
Continue Reading
Philips and Quibim have teamed up to develop AI-enhanced MR imaging and reporting solutions for prostate exams. This partnership aims to improve prostate cancer care efficiency and accuracy, providing an alternative to traditional PSA…
Continue Reading
A new PET-CT scanner has been launched at Norfolk and Norwich University Hospital, to boost access to advanced cancer diagnostics in the East of England.The hospital has advanced its onsite PET-CT service, thanks to…
Continue Reading
Researchers at the University of Massachusetts Amherst have developed a new method of detecting very small amounts of DNA. The breakthrough could allow clinicians to spot genetic markers of disease at the point-of-care, as…
Continue Reading
In the ever-evolving healthcare landscape, where precision and speed are paramount, two powerful forces are converging to reshape how we approach diagnostics and patient care: Point of Care Testing (POCT) and Digital Health. Consider…
Continue Reading
The pace at which generative AI has infiltrated product portfolios and media headlines in 2023 has brought excitement and consternation to those tasked with evaluating its implications for patient care. Owen Hughes reportsWhile AI…
Continue Reading
Mount Sinai researchers have pioneered an AI tool, “HistoAge,” featured in Acta Neuropathologica, capable of estimating brain age, predicting age at death, and identifying age-related brain changes. By analyzing 700 hippocampal section images from…
Continue Reading
Global healthcare investment firm OrbiMed announced it raised more than $4.3 billion in commitments for its private investment funds–OrbiMed Asia Partners V, OrbiMed Royalty & Credit Opportunities IV and OrbiMed Private Investments IX.A range…
Continue Reading
What You Should Know:
PathAI Diagnostics, formerly Poplar Healthcare, a leading laboratory services company, today unveiled the world’s first AI-assisted laboratory-developed test for metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH).MASLD and…
Continue Reading
Researchers at the University of Cincinnati have developed a lateral flow assay that can detect bacterial toxins from Porphyromonas gingivalis, the causative bacteria for gingivitis. The technology could make it easier and faster to…
Continue Reading
